FDA, CDER Discuss AI/ML In Drug Development In Discussion Papers
FDA hopes to engage in “mutual learning” with stakeholders to develop new regulations for the use of AI/ML drug development.
FDA hopes to engage in “mutual learning” with stakeholders to develop new regulations for the use of AI/ML drug development.